Appropriateness of gastroscopy: Gastro-esophageal reflux disease

Endoscopy

Volumn 31, Issue 8, 1999, Pages 596-603

  Bochud, M ^a   Gonvers, Jean Jacques ^b   Vader, J P ^a   Dubois, R W ^c   Burnand, B ^a   Froehlich, F ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^c Protocare Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; OMEPRAZOLE; RANITIDINE;

GASTROESOPHAGEAL REFLUX; GASTROSCOPY; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; REVIEW; FEMALE; HUMAN; MALE; UTILIZATION REVIEW;

FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS; MALE;

EID: 0032589915     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-63     Document Type: Review

References (57)

1. Vader JP, Burnand B, Froehlich F, et al. The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods. Endoscopy 1999; 31: 572-578
2. Vader JP, Froehlich F, Dubois RW, et al. The European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site. Endoscopy 1999; 31: 687-694
3. Kahrilas PJ. Gastroesophageal reflux disease. J Am Med Ass 1996; 276: 983-988
4. Pope CE. Acid-reflux disorders. N Engl J Med 1994; 331: 656-660
5. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol Suppl 1989; 156: 7-13
6. Corder AP, Jones RH, Sadler GH, et al. Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Brit J Clin Pract 1996; 50: 245-248
7. Tibbling L. Epidemiology of gastro-esophageal reflux disease. Scan J Gastroenterol 1984; 19: 14
8. Loof L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scan J Gastroenterol 1993; 28: 113-118
9. Ellis KK, Oehlke M, Helfand M, Liebermann D. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management? Am J Gastroenterol 1997; 92: 1472-1474
10. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997; 92: 1293-1297
11. Werdmuller BFM, Van der Putten ABMM, Loffeld RJLF. The presentation of reflux esophagitis, hiatal hernia, Barrett's esophagus and reflux-like dypsepsia: A prospective clinical and endoscopic study. Dis Esophagus 1996; 9: 285-289
12. McDougall NI, Johnston BT, Kee F, et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patients symptomatology and quality of life. Gut 1996; 38: 481-486
13. Shi G, Bruley des Varannes S, Scarpignato C, et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-464
14. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med 1995; 155: 2165-2173
15. Conio M. Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Endoscopy 1993; 25: 642-644
16. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. Arch Intern Med 1996; 156: 477-484
17. Dakkak M, Hoare RC, Maslin SC, Bennett JR. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia. Gut 1993; 34: 152-155
18. Csendes A, Maluenda F, Braghetto I, et al. Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut 1993; 34: 21-27
19. Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol 1997; 92: 2007-2011
20. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714-718
21. Smout AJ. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study. Scand J Gastroenterol 1996; 218 (Suppl.): 10-15
22. Dimenas E, Glise H, Hallerback B, et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scan J Gastroenterol 1993; 28: 681-687
23. Zhu H, Pace F, Sangaletti O, Bianchi PG. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993; 28: 235-238
24. Beck IT, Champion MC, Lemire S, Thomson ABR. The second Canadian consensus conference on the management of patients with gastroesophageal reflux disease. Can J Gastroenterol 1997; 11: 7B-20B
25. Anonymous. The role of endoscopy in the management of esophagitis. Guidelines for clinical application. Gastrointest Endosc 1988; 34: 9S
26. Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985; 89: 797-804
27. Smith PM, Kerr GD, Cockel R, et al. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology 1994; 107: 1312-1318
28. Hillman AL, Bloom BS, Fendrick AM, Schwartz JS. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med 1992; 152: 1467-1472
29. Canadian Coordinating Office for Health Technology Assessment. Technology Overview: pharmaceutical management of gastroesophageal reflux disease. Based on "Cost-effectiveness of alternative therapies for the long-term management of gastroesophageal reflux disease" by: O'Brien B, Goeree R, Wilkinson J, Levine M, Willan A (eds). CCOHTA Technological Overview. http://www.ccohta.ca/pubs/english/gastro_reflux/intro.htm: 1996
30. Tytgat GNJ, Janssens J, Reynolds JC, et al. Update on the pathophysiology and management of gastrooesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol 1996; 8: 603-611
31. Watson DI, Foreman D, Devitt PG, Jamieson GG. Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplication. Am J Gastroenterol 1997; 92: 222-225
32. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disesase in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group (see comments). N Engl J Med 1992; 326: 786-792
33. Lundell L. Omeprazole or antireflux surgery in the long term management of gastroesophageal reflux disease (GERD): results of a multicentre, randomised clinical trial (Abstract). Gastroenterology 1998; 114: A207
34. Heudebert GR, Marks R, Wilcox CM, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis - a cost-utility analysis. Gastroenterology 1997; 112: 1078-1086
35. Luostarinen M. Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopic results in 109 of 127 consecutive patients. Ann Surg 1993; 21: 329-337
36. Wo JM, Trus TL, Richardson WS, et al. Evaluation and management of postfundoplication dysphagia. Am J Gastroenterol 1996; 91: 2318-2322
37. Harris RA, Kuppermann M, Richter JE. Prevention of recurrences of erosive reflux esophagitis: A cost-effectiveness analysis of maintenance proton pump inhibition. Am J Med 1997; 102: 70-88.
38. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022
39. Varanasi RV. Protective role of Helicobacter pylori infection in gastroesophageal reflux disease (Abstract). Gastroenterology 1998; 114: A322
40. Wu JCY. Prevalence and distribution of H. pylori in gastroesophageal reflux disease: a study in Chinese (Abstract). Gastroenterology 1998; 114: A334
41. Vicari JJ. CAG A positivity may be protective against more severe grades of esophagitis (Abstract). Gastroenterology 1998; 114: A324
42. Friedman G. Is Helicobacter pylori eradication associated with the endoscopic development of esophagitis? (Abstract) Gastroenterology 1998; 114: A124
43. Di Mario F. The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori infection: a 4 year prospective study. (Abstract) Gastroenterology 1998; 114: A105
44. Koike T. Increase of gastric acid secretion after H. pylori eradication caused the development of reflux esophagitis. (Abstract) Gastroenterology 1998; 114: A183
45. Holtmann G. The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole (Abstract). Gastroenterology 1998; 114: A151
46. Talley NJ. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial (Abstract). Gastroenterology 1998; 114: A306
47. Malfertheiner P. Does cure of Helicobacter pylori infection induce heartburn? (Abstract). Gastroenterology 1998; 114: A212
48. Bytzer P. Eradication of H. pylori or long-term acid suppression in duodenal ulcer: a double-blind randomized trial with a two-year follow-up (Abstract). Gastroenterology 1998; 114: A83
49. Peters FTM. Helicobacter pylori and esophageal acid exposure in GERD (Abstract). Gastroenterology 1998; 114: A257
50. Leodolter A. Impact of Helicobacter pylori infection on gastroesophageal reflux (Abstract). Gastroenterology 1998; 114: A200
51. Vignieri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110
52. Fennerty MB. Barrett's esophagus: what do we really know about this disease? Am J Gastroenterol 1997; 92: 1-3
53. Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997; 92: 27-31
54. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium (see comments). Gastroenterology 1992; 103: 1241-1245
55. De Bosset V, Gonvers JJ, Froehlich F, et al. Appropriateness of gastroscopy: Bleeding and dysphagia. Endoscopy 1999; 31: 615-622
56. Ollyo JB, Fontolliet C, Brossard E, et al. La nouvelle classification de Savary des oesophagites de reflux. Acta Endoscopia 1992; 22: 307-320
57. Bochud M, Gonvers JJ, Vader JP, et al. Appropriateness of gastroscopy: Barrett's esophagus. Endoscopy 1999; 31: 604-610